Impaired monocyte activation in schizophrenia.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Psychiatry Research

• Publication date

  2012-08-15

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.psychres.2011.12.049PMID 22429483
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Impaired neuroendocrine and immune response to acute stress in medication-naive patients with a first episode of psychosis.

  2012cited by this paper
• TLR ligands induce synergistic interferon-β and interferon-λ1 gene expression in human monocyte-derived dendritic cells.

  2011cited by this paper
• Expression of anti-cardiolipin antibodies and inflammatory associated factors in patients with schizophrenia.

  2011cited by this paper
• Schizophrenia genes, epigenetics and psychoneuroimmunology therapeutics: all make sense now?

  2011cited by this paper
• The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder

  2010cited by this paper
• Neural injury following stroke: are Toll‐like receptors the link between the immune system and the CNS?

  2010cited by this paper
• Oxidative stress and neopterin abnormalities in schizophrenia: a longitudinal study.

  2010cited by this paper
• The association of infectious agents and schizophrenia

  2010cited by this paper
• Cerebrospinal fluid analysis in affective and schizophrenic spectrum disorders: identification of subgroups with immune responses and blood-CSF barrier dysfunction.

  2010cited by this paper
• CO2 Modulates the Inflammatory Cytokine Release of Primary Human Pleural Macrophages

  2010cited by this paper
• Apolipoprotein E inhibits toll-like receptor (TLR)-3- and TLR-4-mediated macrophage activation through distinct mechanisms.

  2010cited by this paper
• Toll‐like receptor 4 in CNS pathologies

  2010cited by this paper
• Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment.

  2010cited by this paper
• Glial cells in schizophrenia: pathophysiological significance and possible consequences for therapy

  2009cited by this paper
• Persistently increased serum soluble interleukin-2 receptors in continuously ill patients with schizophrenia.

  2009cited by this paper
• Short-Term Improvement by Minocycline Added to Olanzapine Antipsychotic Treatment in Paranoid Schizophrenia

  2009cited by this paper
• Neuroinflammation in Schizophrenia-Related Psychosis: A PET Study

  2009cited by this paper
• A review of the fetal brain cytokine imbalance hypothesis of schizophrenia.

  2009cited by this paper
• Neuroleptic treatment increases soluble IL-2 receptors and decreases soluble IL-6 receptors in schizophrenia

  2008cited by this paper
• Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study.

  2008cited by this paper
• Infections in the CNS during childhood and the risk of subsequent psychotic illness: a cohort study of more than one million Swedish subjects.

  2008cited by this paper
• An electron microscopic study of typical lymphocytes and atypical cells of peripheral blood in patients with schizophrenia

  2008cited by this paper
• [An electron microscopic study of typical lymphocytes and atypical cells of peripheral blood in patients with schizophrenia].

  2008cited by this paper
• Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide.

  2008cited by this paper
• Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review.

  2008cited by this paper
• Neuroinflammation Associated with Aging Sensitizes the Brain to the Effects of Infection or Stress

  2008cited by this paper
• Microglia: active sensor and versatile effector cells in the normal and pathologic brain

  2007cited by this paper
• Microglia-mediated neurotoxicity: uncovering the molecular mechanisms

  2007cited by this paper
• Editors' Introduction: Schizophrenia and Toxoplasmosis

  2007cited by this paper
• T- and B-lymphocytes in patients with schizophrenia in acute psychotic episode and the course of the treatment.

  2007influential reference
• Schizophrenia and toxoplasmosis.

  2007cited by this paper
• Monocytic, Th1 and Th2 Cytokine Alterations in the Pathophysiology of Schizophrenia

  2007cited by this paper
• Possible anti-catatonic effects of minocycline in patients with schizophrenia.

  2007cited by this paper
• The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells.

  2005cited by this paper
• TLR Signaling Tailors Innate Immune Responses in Human Microglia and Astrocytes1

  2005cited by this paper
• Investigations of cytokine production in whole blood cultures of paranoid and residual schizophrenic patients

  2005influential reference
• Quantitative analysis of activated microglia, ramified and damage of processes in the frontal and temporal lobes of chronic schizophrenics.

  2005cited by this paper
• Glial cell dysfunction in schizophrenia indicated by increased S100B in the CSF

  2004cited by this paper
• Antibodies to infectious agents in individuals with recent onset schizophrenia

  2004cited by this paper
• T-helper types 1, 2, and 3 cytokine interactions in symptomatic manic patients.

  2004cited by this paper
• Impaired monocyte cytokine production in critically ill patients with acute renal failure.

  2004cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)

  2003cited by this paper
• Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia.

  2002cited by this paper
• [The changes of the function of lymphocytes natural killers in schizophrenics].

  2002cited by this paper
• Cutting Edge: Role of Toll-Like Receptor 1 in Mediating Immune Response to Microbial Lipoproteins1

  2002influential reference
• T-helper-1 and T-helper-2 responses in psychiatric disorders.

  2001influential reference
• Increased frequency of activated lymphocytes in the cerebrospinal fluid of patients with acute schizophrenia.

  2001cited by this paper
• Interferon-gamma modifies cytokine release in vitro by monocytes from surgical patients.

  2001cited by this paper
• Increase in HLA‐DR Immunoreactive Microglia in Frontal and Temporal Cortex of Chronic Schizophrenics

  2000cited by this paper
• Decreased in vitro production of interferon-gamma and interleukin-2 in whole blood of patients with schizophrenia during treatment

  2000cited by this paper
• Higher natural killer cell activity in schizophrenic patients: the impact of serum factors, medication, and smoking.

  2000cited by this paper
• Evidence for activation of microglia in patients with psychiatric illnesses.

  1999cited by this paper
• Measurement of neopterin, kynurenine and tryptophan in sera of schizophrenic patients

  1999cited by this paper
• Interleukin‐1, but Not Stress, Stimulates Glucocorticoid Output during Early Postnatal Life in Mice a

  1998cited by this paper
• Administration of Interleukin‐1 at Birth Affects Dopaminergic Neurons in Adult Mice a

  1998cited by this paper
• Increased serum neopterin levels in acutely ill and recovered schizophrenic patients.

  1998cited by this paper
• Immunological Dysfunction in Schizophrenia: A Systematic Approach

  1998cited by this paper
• The long-term course of childhood-onset schizophrenia: a 42-year followup.

  1997cited by this paper
• Production of interferon-gamma in families with multiple occurrence of schizophrenia.

  1997cited by this paper
• Changes of immunological functions after acute exacerbation in schizophrenia.

  1994cited by this paper
• Depressed natural killer cell activity in schizophrenic patients.

  1994cited by this paper
• T‐cells and psychopathology in schizophrenia: relationship to the outcome of neuroleptic therapy

  1993cited by this paper
• Triple immunofluorescence flow cytometry, using whole blood, of CD4+ and CD8+ lymphocytes expressing CD45RO and CD45RA.

  1993cited by this paper
• Predicting outcome in child and adolescent (early onset) schizophrenia and bipolar disorder.

  1992cited by this paper
• Cellular immunity in schizophrenic patients before and during neuroleptic treatment.

  1991influential reference
• Reduced natural killer cell cytotoxicity in depression but not in schizophrenia.

  1991cited by this paper
• Lytic effector cell function in schizophrenia and depression.

  1988influential reference

• Pharmacological Effects, Mechanisms of Action, and Clinical Applications of Traditional Chinese Medicine Angong Niuhuang Pill

  2026cites this paper
• Involvement of virus infections and antiviral agents in schizophrenia

  2025cites this paper
• The evaluation of maternal immune activation and the development of schizophrenia in offspring of rats

  2025cites this paper
• Association of TNF and TLR2 genes with blood parameter levels in Mexican patients with schizophrenia

  2025cites this paper
• Sex-specific Associations between Immune Parameters and Clinical Symptoms in First-episode Patients with Schizophrenia

  2025cites this paper
• Peripheral and central innate immune alterations in schizophrenia and bipolar disorder: a systematic review of NK cells, monocytes and macrophages

  2025cites this paper
• Complete blood count-based inflammation indexes and symptom severity in people with bipolar disorder: an analysis based on structural equation modelling

  2025cites this paper
• Monocytic TLR4 expression and activation in schizophrenia: A systematic review and meta-analysis

  2025influential citation
• The role of the microbiota-gut-brain axis in schizophrenia: an immunological perspective

  2025cites this paper
• An exploratory study of the damage markers NfL, GFAP, and t-Tau, in cerebrospinal fluid and other findings from a patient cohort enriched for suspected autoimmune psychiatric disease

  2024cites this paper
• Immunophenotypes in psychosis: is it a premature inflamm-aging disorder?

  2024influential citation
• Significance of chitinase-3-like protein 1 in the pathogenesis of inflammatory diseases and cancer

  2024cites this paper
• The causal relationship between immune cell traits and schizophrenia: a Mendelian randomization analysis

  2024cites this paper
• Role of sulfidogenic members of the gut microbiota in human disease.

  2024cites this paper
• Inflammatory mediators in major depression and bipolar disorder

  2024cites this paper
• Counting the Toll of Inflammation on Schizophrenia—A Potential Role for Toll-like Receptors

  2023cites this paper
• Monocyte/HDL Cholesterol Ratios as a New Inflammatory Marker in Patients with Schizophrenia

  2023cites this paper
• Effects of Current Psychotropic Drugs on Inflammation and Immune System.

  2023cites this paper
• Gene expression profiling of monocytes in recent-onset schizophrenia.

  2023influential citation
• Toll-Like Receptor mRNA Levels in Schizophrenia: Association With Complement Factors and Cingulate Gyrus Cortical Thinning.

  2023cites this paper
• Experiences in Implementing Immunopsychiatry in Real Life

  2023cites this paper
• The Emerging Role of Toll-Like Receptor-Mediated Neuroinflammatory Signals in Psychiatric Disorders and Acquired Epilepsy

  2023influential citation
• Microglia and Other Cellular Mediators of Immunological Dysfunction in Schizophrenia: A Narrative Synthesis of Clinical Findings

  2023cites this paper
• Schizophrenia and the COVID-19 pandemic: A narrative review from the biomedical perspective.

  2023cites this paper
• Dysfunctional monocytic toll-like receptor 4 signaling pathway and cognitive deficits in chronic schizophrenia patients with tardive dyskinesia.

  2022cites this paper
• The Issue of Monocyte Activation in ASD: Troubles with Translation

  2022cites this paper
• Alterations in innate immune defense distinguish first-episode schizophrenia patients from healthy controls

  2022cites this paper
• The relationship between TLR4/NF-κB/IL-1β signaling, cognitive impairment, and white-matter integrity in patients with stable chronic schizophrenia

  2022cites this paper
• Toll-Like Receptor 4 Gene Polymorphisms and Susceptibility to Schizophrenia: A Case-Control Study

  2022cites this paper
• Old and New Biomarkers for Infection, Inflammation, and Autoimmunity in Treatment-Resistant Affective and Schizophrenic Spectrum Disorders

  2022cites this paper
• Targeting neurotransmitter-mediated inflammatory mechanisms of psychiatric drugs to mitigate the double burden of multimorbidity and polypharmacy

  2021cites this paper
• Human Endogenous Retrovirus as Therapeutic Targets in Neurologic Disease

  2021cites this paper
• Roles of inflammation in intrinsic pathophysiology and antipsychotic drug-induced metabolic disturbances of schizophrenia.

  2021cites this paper
• Monocyte count in schizophrenia and related disorders: a systematic review and meta-analysis

  2020cites this paper
• The prefrontal cortex as a target for atypical antipsychotics in schizophrenia, lessons of neurodevelopmental animal models.

  2020cites this paper
• Expression and Functionality Study of 9 Toll-Like Receptors in 33 Drug-Naïve Non-Affective First Episode Psychosis Individuals: A 3-Month Study

  2020cites this paper
• Markers of systemic inflammation and systemic endotoxinemia in patients with acute endogenous psychoses

  2020cites this paper
• Expression and functionality study of 9 Toll-like receptors in drug-naïve non-affective first episode psychosis individuals: a 3-month study

  2020cites this paper
• Effects of electroconvulsive therapy in the systemic inflammatory balance of patients with severe mental disorder

  2019cites this paper
• The expression of toll-like receptors in peripheral blood mononuclear cells is altered in schizophrenia.

  2019cites this paper
• Cytokines, Oxidative Stress and Cellular Markers of Inflammation in Schizophrenia.

  2019cites this paper
• Neutrophil-lymphocyte ratio, monocyte-lymphocyte ratio and platelet-lymphocyte ratio in non-affective psychosis: A meta-analysis and systematic review

  2019cites this paper
• More dampened monocytic Toll-like receptor 4 response to lipopolysaccharide and its association with cognitive function in Chinese Han first-episode patients with schizophrenia.

  2019cites this paper
• In vitro cytokine synthesis in unstimulated and mitogen-stimulated peripheral blood mononuclear cells from individuals with schizophrenia

  2019cites this paper
• University of Birmingham Cytokines, oxidative stress and cellular markers of inflammation in schizophrenia

  2019cites this paper
• Increased circulating regulatory T cells in medicated people with schizophrenia.

  2018cites this paper
• Immunological Processes in Schizophrenia Pathology: Potential Biomarkers?

  2018cites this paper
• Monocyte activation detected prior to a diagnosis of schizophrenia in the US Military New Onset Psychosis Project (MNOPP).

  2018cites this paper
• Syncytin-1, an endogenous retroviral protein, triggers the activation of CRP via TLR3 signal cascade in glial cells.

  2018cites this paper
• Schizophrenia-related dysbindin-1 gene is required for innate immune response and homeostasis in the developing subventricular zone

  2018cites this paper
• Increased number of monocytes and plasma levels of MCP‐1 and YKL‐40 in first‐episode psychosis

  2018cites this paper
• Human Endogenous Retroviral Envelope Protein Syncytin-1 and Inflammatory Abnormalities in Neuropsychological Diseases

  2018cites this paper
• Biomarkers in Psychiatry

  2018cites this paper
• Deciphering the interplay between peripheral and central cytokine- and kynurenine pathways : importance for the pathophysiology of schizophrenia

  2018cites this paper
• Uniting the neurodevelopmental and immunological hypotheses: Neuregulin 1 receptor ErbB and Toll-like receptor activation in first-episode schizophrenia

  2017cites this paper
• Impaired monocyte activation in schizophrenia: ultrastructural abnormalities and increased IL-1β production

  2017cites this paper
• Paliperidone reverts Toll‐like receptor 3 signaling pathway activation and cognitive deficits in a maternal immune activation mouse model of schizophrenia

  2017cites this paper
• Antipsychotics influence Toll-like receptor (TLR) expression and its relationship with cognitive functions in schizophrenia.

  2017cites this paper
• Inflammatory, cardio-metabolic and diabetic profiling of chronic schizophrenia

  2017cites this paper
• Inflammation, Immune Function, and Schizophrenia: An Overview

  2017cites this paper
• Differential regulation of the TLR4 signalling pathway in post-mortem prefrontal cortex and cerebellum in chronic schizophrenia: Relationship with SP transcription factors.

  2017cites this paper
• Towards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future Directions

  2017cites this paper
• Neuroinflammation in Schizophrenia: A Critical Review and The Future

  2016cites this paper
• Oral Health Is a Challenging Problem for Patients with Schizophrenia: A Narrative Review

  2016cites this paper
• Tryptophan Metabolism Along the Kynurenine Pathway Downstream of Toll‐like Receptor Stimulation in Peripheral Monocytes

  2016cites this paper
• The Immunology of Behavior ‖ Towards an Immunophenotype of Schizophrenia : Progress , Potential Mechanisms , and Future Directions Running Title : Schizophrenia Immunophenotype

  2016cites this paper
• Innate Immune Response and Psychotic Disorders

  2016cites this paper
• A novel pipeline for drug discovery in neuropsychiatric disorders using high-content single-cell screening of signalling network responses ex vivo

  2016cites this paper
• eview nnate immune receptor Toll-like receptor 4 signalling in europsychiatric diseases

  2016cites this paper
• Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling.

  2016cites this paper
• For whom the endocannabinoid tolls: Modulation of innate immune function and implications for psychiatric disorders.

  2016influential citation
• Niacin Skin Sensitivity Is Increased in Adolescents at Ultra-High Risk for Psychosis

  2016cites this paper
• Innate immune receptor Toll-like receptor 4 signalling in neuropsychiatric diseases.

  2016cites this paper
• Evidence of activation of the Toll-like receptor-4 proinflammatory pathway in patients with schizophrenia.

  2016cites this paper
• The Microbiota and Gut-Brain Axis: Contributions to the Immunopathogenesis of Schizophrenia.

  2016cites this paper
• Maternal immune activation epigenetically regulates expression of the serotonin transporter in the adult offspring brain

  2015cites this paper
• Associations Between Maternal Infection During Pregnancy, Childhood Infections, and the Risk of Subsequent Psychotic Disorder--A Swedish Cohort Study of Nearly 2 Million Individuals.

  2015cites this paper
• Immune aging, dysmetabolism, and inflammation in neurological diseases

  2015cites this paper
• Altered Activation of Innate Immunity Associates with White Matter Volume and Diffusion in First-Episode Psychosis

  2015cites this paper
• Adjunctive use of interferon γ inducer for treatment of patients with schizophrenia

  2015cites this paper
• INFECTION EARLY IN LIFE AND RISK OF NON-AFFECTIVE PSYCHOSIS

  2015cites this paper
• The poly(I:C)-induced maternal immune activation model in preclinical neuropsychiatric drug discovery.

  2015cites this paper
• Influence of maternal infections on neonatal acute phase proteins and their interaction in the development of non-affective psychosis

  2015cites this paper
• Paliperidone Prevents Brain Toll-Like Receptor 4 Pathway Activation and Neuroinflammation in Rat Models of Acute and Chronic Restraint Stress

  2015cites this paper
• Toll-like receptor-2 deficiency induces schizophrenia-like behaviors in mice

  2015cites this paper
• Inflammation in schizophrenia: A question of balance.

  2015cites this paper
• [Immunological treatment options for schizophrenia].

  2014cites this paper
• Technological advances for deciphering the complexity of psychiatric disorders: merging proteomics with cell biology.

  2014cites this paper
• Autoimmunity, inflammation, and psychosis: a search for peripheral markers.

  2014cites this paper
• Mikroglia und immunologische Mechanismen in der neuropsychiatrischen Forschung

  2014cites this paper
• Project 1: investigating the polyclonal nature of Glioblastoma through the development of a 3-dimensional spheroid model And Project 2: Investigating TNF-α in first episode psychosis medication naïve schizophrenia patients to demographically controlled individuals and pharmacological manipulation of

  2014cites this paper
• Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia.

  2013cites this paper
• Anti-inflammatory treatment in schizophrenia.

  2013cites this paper
• Impact of different antipsychotics on cytokines and tryptophan metabolites in stimulated cultures from patients with schizophrenia.

  2013cites this paper
• Evidence for a Dysregulated Immune System in the Etiology of Psychiatric Disorders

  2013cites this paper
• Oligodendroglial Alterations and the Role of Microglia in White Matter Injury: Relevance to Schizophrenia

  2013cites this paper
• The role of anti-inflammatory treatment in psychiatric disorders.

  2013cites this paper
• Variation in the major histocompatibility complex [MHC] gene family in schizophrenia: associations and functional implications.

  2013cites this paper
• The TRIPS (Toll-like receptors in immuno-inflammatory pathogenesis) Hypothesis: a novel postulate to understand schizophrenia.

  2013cites this paper
• Lack of association of IL-6 (-174 G>C) and TNF-α (-238 G>A) variants with paranoid schizophrenia in Indian Bengalee population.

  2013cites this paper